Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b

Circulation Research

Volumn 113, Issue 9, 2013, Pages 1054-1064

  Rodríguez, José M ^a   Wolfrum, Susanne ^a,d   Robblee, Megan ^a   Chen, Kwan Y ^a   Gilbert, Zachary N ^a   Choi, Jae Hoon ^a,b   Teupser, Daniel ^a,c   Breslow, Jan L ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Hanyang University   (South Korea)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ETH ZURICH   (Switzerland)

Author keywords

Atherosclerosis; Gene expression; Genetic susceptibility; Mice; Mouse model; Quantitative trait loci

Indexed keywords

ALDH8A1 PROTEIN; AMINO ACID; HBS1L PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN MYB; RAET1E PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; RAET1E PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CHROMOSOME 10; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS MAPPING; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; ANIMAL; AORTA; AORTA DISEASE; BAGG ALBINO MOUSE; C57BL MOUSE; CHROMOSOME; COMPARATIVE STUDY; CROSS BREEDING; DISEASE MODEL; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLISM; MUTATION; PATHOLOGY; PHENOTYPE; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; SPECIES DIFFERENCE; TRANSGENIC MOUSE;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHROMOSOMES, MAMMALIAN; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; PHENOTYPE; PROMOTER REGIONS, GENETIC; QUANTITATIVE TRAIT LOCI; RECEPTORS, LDL; SPECIES SPECIFICITY;

EID: 84885991755     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.302052     Document Type: Article

References (39)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics- 2013 update: a report from the American Heart Association. Circulation. 2013;127:e6-e245
2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325.
3. Lusis AJ. Genetics of atherosclerosis. Trends Genet. 2012;28:267-275.
4. Welch CL. Beyond genome-wide association studies: the usefulness of mouse genetics in understanding the complex etiology of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:207-215.
5. Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:1104-1115.
6. Hunter KW, Crawford NP. The future of mouse QTL mapping to diagnose disease in mice in the age of whole-genome association studies. Annu Rev Genet. 2008;42:131-141.
7. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE; Mouse Genome Database Group. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 2012;40:D881-D886.
8. Abiola O, Angel JM, Avner P, et al; Complex Trait Consortium. The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet. 2003;4:911-916.
9. Drinkwater NR, Gould MN. The long path from QTL to gene. PLoS Genet. 2012;8:e1002975.
10. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, Shu P, Moore KJ, Breslow JL, Smith JD. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19:1960-1968. (Pubitemid 29379929)
11. Dansky HM, Shu P, Donavan M, Montagno J, Nagle DL, Smutko JS, Roy N, Whiteing S, Barrios J, McBride TJ, Smith JD, Duyk G, Breslow JL, Moore KJ. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics. 2002;160:1599-1608. (Pubitemid 34454381)
12. Smith JD, James D, Dansky HM, Wittkowski KM, Moore KJ, Breslow JL. In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:117-122. (Pubitemid 36091635)
13. Teupser D, Tan M, Persky AD, Breslow JL. Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice. Proc Natl Acad Sci U S A. 2006;103:123-128. (Pubitemid 43076115)
14. Teupser D, Wolfrum S, Tan M, Persky AD, Dansky HM, Breslow JL. Novel strategy using F1-congenic mice for validation of QTLs: studies at the proximal chromosome 10 atherosclerosis susceptibility locus. Arterioscler Thromb Vasc Biol. 2009;29:678-683.
15. Wolfrum S, Rodríguez JM, Tan M, Chen KY, Teupser D, Breslow JL. The mouse atherosclerosis locus at chromosome 10 (Ath11) acts early in lesion formation with subcongenic strains delineating 2 narrowed regions. Arterioscler Thromb Vasc Biol. 2010;30:1583-1590.
16. Cox A, Ackert-Bicknell CL, Dumont BL, Ding Y, Bell JT, Brockmann GA, Wergedal JE, Bult C, Paigen B, Flint J, Tsaih SW, Churchill GA, Broman KW. A new standard genetic map for the laboratory mouse. Genetics. 2009;182:1335-1344.
17. Burkhardt R, Sündermann S, Ludwig D, Ceglarek U, Holdt LM, Thiery J, Teupser D. Cosegregation of aortic root atherosclerosis and intermediate lipid phenotypes on chromosomes 2 and 8 in an intercross of C57BL/6 and BALBc/ByJ low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol. 2011;31:775-784.
18. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781-790. (Pubitemid 37328656)
19. Samarakoon A, Chu H, Malarkannan S. Murine NKG2D ligands: "double, double toil and trouble". Mol Immunol. 2009;46:1011-1019.
20. Carayannopoulos LN, Naidenko OV, Kinder J, Ho EL, Fremont DH, Yokoyama W. Ligands for murine NKG2D display heterogeneous binding behavior. Eur J Immunol. 2002;32:597-605. (Pubitemid 34257536)
21. Ogasawara K, Lanier LL. NKG2D in NK and T cell-mediated immunity. J Clin Immunol. 2005;25:534-540. (Pubitemid 43011745)
22. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev. 2010;235:267-285.
23. Whitman SC, Ramsamy TA. Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies. Can J Physiol Pharmacol. 2006;84:67-75. (Pubitemid 44011952)
24. Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol. 2009;183:340-351.
25. Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene. 2008;27:5944-5958.
26. Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, Stevens AM, Spies T, Groh V. Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. J Exp Med. 2009;206:793-805.
27. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009;29:1419-1423.
28. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev. 2006;214:73-91. (Pubitemid 44707903)
29. Matsumoto G, Nghiem MP, Nozaki N, Schmits R, Penninger JM. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J Immunol. 1998;160:5781-5789. (Pubitemid 28298035)
30. Kriegeskorte AK, Gebhardt FE, Porcellini S, Schiemann M, Stemberger C, Franz TJ, Huster KM, Carayannopoulos LN, Yokoyama WM, Colonna M, Siccardi AG, Bauer S, Busch DH. NKG2D-independent suppression of T cell proliferation by H60 and MICA. Proc Natl Acad Sci U S A. 2005;102:11805-11810. (Pubitemid 41170806)
31. Popa N, Cedile O, Pollet-Villard X, Bagnis C, Durbec P, Boucraut J. RAE- 1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres. Glia. 2011;59:35-44.
32. Eagle RA, Jafferji I, Barrow AD. Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr Immunol Rev. 2009;5:22-34.
33. Davies RW, Wells GA, Stewart AF, et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet. 2012;5: 217-225.
34. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-109
35. Kristiansson K, Perola M, Tikkanen E, et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 2012;5:242-249.
36. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466: 707-713.
37. Aouizerat BE, Vittinghoff E, Musone SL, Pawlikowska L, Kwok PY, Olgin JE, Tseng ZH. GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc Disord. 2011;11:29.
38. Samani NJ, Erdmann J, Hall AS, et al; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-453. (Pubitemid 47204873)
39. Yang Q, Kathiresan S, Lin JP, Tofler GH, O'Donnell CJ. Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet. 2007;8(Suppl 1):S12.